ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation (NCT03987256) | Clinical Trial Compass
UnknownNot Applicable
ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation
Switzerland58 participantsStarted 2020-01-01
Plain-language summary
This study evaluates the effect of platelet-rich plasma (PRP) use during needling of the extensor carpalis radialis brevis tendon, after failure of proper reeducation including focal extra-corporal shockwave therapy (ESWT). Half of the patients with receive PRP and needling, and half of the patients will receive needling alone.
During the reeducation, the clinical evaluation will be monitored and reported as in a case series.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Lesion of the ECRB tendon on ultrasonography (\[hypoechogenic area during rest OR hypoechogenic area during active contraction, OR compressibility of the tendon OR doppler signal\] AND \[positive sonopalpation\])
* Failure to rehabilitation program including shockwave therapy defined as the need for the patient undergoing additional therapies
Exclusion Criteria:
* Presence on ultrasound of an isolated lesion of the superficial epicondylar tendons as described above, with intact ECRB
* Presence on ultrasound of any of: radiohumeral synovial material; interruption of the lateral collateral ligament; radial nerve entrapment, i.e. under the arcade of Frohse; osteochondral lesion; joint effusion. Note: calcic enthesophytes are not considered as an exclusion criteria
* Clinical presence of cervicobrachialgia, or pain irradiating into the hand
* Corticosteroids: oral intake or infiltration on the last 3 months
* Proximal radius fracture history
* Active inflammatory rheumatic disorders
* Diabetes mellitus
* Immunocompromized status
* Allergy to local anesthetics
* Bleeding disorders or current anticoagulation therapy
* Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiopulmonary significant insufficiency, etc.)
* Known or suspected non-compliance, drug or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participa…